Search





Search





Markets
/
Stocks
/
beam
/

Beam Therapeutics Inc

BEAM

Add to Watchlist

25.520USD

-0.970-3.66%

Close 07-31 16:00（ET）Quotes delayed by 15 min

2.63BMarket Cap

LossP/E TTM

Beam Therapeutics Inc

25.520

-0.970-3.66%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

BEAM Cash Flow Statement

You can access the annual and quarterly cash flow statements of Beam Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-23.71%-128.51M

-9.07%-83.29M

7.54%-81.48M

7.90%-76.45M

-4.15%-103.88M

-156.54%-76.36M

1.85%-88.13M

1.96%-83.01M

9.17%-99.75M

295.22%135.07M

-20.52%-89.78M

-61.97%-84.67M

-150.26%-109.81M

-3880.93%-69.19M

-2577.42%-74.50M

-60.72%-52.28M

666.36%218.49M

107.53%1.83M

114.18%3.01M

-42.43%-32.53M

-40.83%-38.58M

-36.51%-24.30M

-24.84%-21.21M

-101.14%-22.84M

-5.94%-27.39M

-499.73%-17.80M

-80.54%-16.99M

---11.35M

---25.86M

---2.97M

---9.41M

Net income from continuing operations

13.68%-94.32M

370.38%244.30M

-16.61%-112.73M

-12.34%-102.29M

-10.74%-109.27M

-163.27%-90.35M

-0.60%-96.67M

-10.00%-91.05M

-2.29%-98.67M

472.36%142.80M

12.31%-96.09M

-15.05%-82.78M

-39.36%-96.46M

40.73%-38.35M

-289.70%-109.58M

5.64%-71.95M

65.66%-69.21M

32.22%-64.71M

18.38%-28.12M

-122.84%-76.25M

-561.76%-201.56M

-242.78%-95.46M

-81.28%-34.45M

-91.58%-34.22M

-123.79%-30.46M

-10.54%-27.85M

73.29%-19.00M

---17.86M

---13.61M

---25.19M

---71.15M

Operating gains losses

1.39%5.61M

4.13%5.67M

1.55%5.56M

-0.68%5.54M

1.79%5.53M

1.51%5.44M

5.55%5.47M

15.78%5.58M

16.87%5.43M

35.95%5.36M

49.35%5.19M

40.90%4.82M

40.31%4.65M

49.73%3.94M

98.46%3.47M

104.79%3.42M

136.91%3.31M

107.08%2.63M

43.68%1.75M

45.76%1.67M

27.09%1.40M

26.95%1.27M

34.14%1.22M

33.45%1.15M

49.66%1.10M

87.99%1.00M

1318.75%908.00K

--858.00K

--735.00K

--533.00K

--64.00K

Other non-cash items

83.67%-196.00K

65.82%-740.00K

515.89%13.25M

44.22%-1.97M

71.53%-1.20M

56.28%-2.17M

43.08%-3.19M

30.72%-3.53M

7.93%-4.21M

-70.23%-4.95M

-421.04%-5.60M

-465.19%-5.10M

-384.35%-4.58M

-234.55%-2.91M

-150.61%-1.07M

-39.83%1.40M

-98.98%1.61M

-2.96%2.16M

-65.40%2.12M

119.28%2.32M

14373.51%157.33M

-8.50%2.23M

260.13%6.13M

1.73%1.06M

-17.59%1.09M

-79.45%2.44M

-97.08%1.70M

--1.04M

--1.32M

--11.85M

--58.33M

Change in working capital

-118.35%-55.62M

-390.84%-101.86M

72.17%-7.12M

113.28%3.44M

32.90%-25.47M

34.14%-20.75M

-30.32%-25.60M

-26.59%-25.91M

15.33%-37.96M

-204.42%-31.51M

-89.35%-19.64M

-1753.47%-20.47M

-116.54%-44.83M

-127.56%-10.35M

-118.59%-10.37M

-89.79%1.24M

16835.43%271.11M

509.87%37.56M

900.57%55.79M

783.20%12.12M

64.89%-1.62M

35.18%6.16M

312.26%5.58M

-169.95%-1.77M

69.58%-4.61M

-45.66%4.56M

-166.70%-2.63M

--2.54M

---15.17M

--8.38M

---985.00K

-Change in receivables

----

100.00%0.00

----

---146.00K

--0.00

-100.00%0.00

100.00%0.00

-100.00%0.00

100.00%0.00

--300.00M

---307.40M

--50.00M

---50.00M

----

-Change in prepaid expenses

-65122.45%-31.86M

100.76%59.00K

-6.82%1.63M

-55.52%2.78M

100.89%49.00K

-318.68%-7.81M

148.89%1.74M

223.79%6.25M

34.18%-5.53M

736.36%3.57M

-1417.87%-3.57M

-13.42%1.93M

8.49%-8.40M

-4415.38%-561.00K

-106.12%-235.00K

400.67%2.23M

-288.37%-9.19M

100.63%13.00K

600.55%3.84M

-12.96%-741.00K

33.55%-2.37M

-358.34%-2.06M

143.56%548.00K

-76.34%-656.00K

-737.41%-3.56M

-39.35%797.00K

44.92%-1.26M

---372.00K

---425.00K

--1.31M

---2.28M

-Change in other current assets

----

--0.00

----

--0.00

100.00%0.00

-100.00%0.00

-233.33%-12.00K

-140.26%-185.00K

12.50%-98.00K

102.70%12.00K

--9.00K

1.28%-77.00K

---112.00K

---444.00K

--0.00

---78.00K

----

-Change in other current liabilities

17.70%-6.22M

-2157.90%-113.91M

56.92%-5.75M

24.66%-8.52M

-19.40%-7.56M

94.98%-5.04M

22.96%-13.36M

37.49%-11.31M

73.35%-6.33M

-401.12%-100.56M

-9.39%-17.34M

-642.82%-18.09M

-17370.59%-23.76M

-106.67%-20.07M

-1844.79%-15.85M

-104.88%-2.44M

-138.60%-136.00K

27602.19%300.87M

-139.05%-815.00K

832483.33%49.94M

-850.00%-57.00K

-18133.33%-1.09M

29914.29%2.09M

99.66%-6.00K

99.95%-6.00K

-100.10%-6.00K

-101.06%-7.00K

---1.75M

---12.17M

--6.20M

--663.00K

Cash from non-recurring investing activities

Cash from operating activities

-23.71%-128.51M

-9.07%-83.29M

7.54%-81.48M

7.90%-76.45M

-4.15%-103.88M

-156.54%-76.36M

1.85%-88.13M

1.96%-83.01M

9.17%-99.75M

295.22%135.07M

-20.52%-89.78M

-61.97%-84.67M

-150.26%-109.81M

-3880.93%-69.19M

-2577.42%-74.50M

-60.72%-52.28M

666.36%218.49M

107.53%1.83M

114.18%3.01M

-42.43%-32.53M

-40.83%-38.58M

-36.51%-24.30M

-24.84%-21.21M

-101.14%-22.84M

-5.94%-27.39M

-499.73%-17.80M

-80.54%-16.99M

---11.35M

---25.86M

---2.97M

---9.41M

Investing cash flow

Net cash from continuing investing activities

-27.18%2.23M

25.72%3.73M

217.76%5.01M

59.92%3.14M

25.72%3.06M

-17.25%2.97M

-80.16%1.58M

-87.88%1.96M

-59.48%2.44M

-56.55%3.59M

-32.57%7.95M

-25.25%16.18M

-17.11%6.02M

-38.21%8.26M

103.93%11.79M

33.74%21.64M

-36.76%7.26M

64.54%13.37M

105.04%5.78M

583.73%16.18M

276.82%11.48M

276.16%8.13M

98.66%2.82M

-64.05%2.37M

29.40%3.05M

-80.75%2.16M

117.97%1.42M

--6.58M

--2.35M

--11.22M

--651.00K

Capital expenditures

-27.18%2.23M

25.72%3.73M

217.76%5.01M

59.92%3.14M

25.72%3.06M

-17.25%2.97M

-80.16%1.58M

-87.88%1.96M

-59.48%2.44M

-56.55%3.59M

-32.57%7.95M

-25.25%16.18M

-17.11%6.02M

-38.21%8.26M

103.93%11.79M

33.74%21.64M

-36.76%7.26M

64.54%13.37M

105.04%5.78M

583.73%16.18M

276.82%11.48M

276.16%8.13M

98.66%2.82M

-64.05%2.37M

29.40%3.05M

-80.75%2.16M

117.97%1.42M

--6.58M

--2.35M

--11.22M

--651.00K

Net cash flow from disposal of fixed assets

-27.18%2.23M

25.72%3.73M

217.76%5.01M

59.92%3.14M

25.72%3.06M

-17.25%2.97M

-80.16%1.58M

-87.88%1.96M

-59.48%2.44M

-56.55%3.59M

-32.57%7.95M

-25.25%16.18M

-17.11%6.02M

-38.21%8.26M

103.93%11.79M

33.74%21.64M

-36.76%7.26M

64.54%13.37M

105.04%5.78M

583.73%16.18M

276.82%11.48M

276.16%8.13M

98.66%2.82M

-64.05%2.37M

29.40%3.05M

-80.75%2.16M

117.97%1.42M

--6.58M

--2.35M

--11.22M

--651.00K

Net cash flow from business transactions

----

--0.00

---78.00K

----

--0.00

----

--0.00

-100.00%0.00

--0.00

--620.00K

----

Net cash flow from investment products

122.54%27.50M

-210.64%-143.00M

147.39%65.00M

-287.00%-167.28M

-139.14%-122.02M

27.10%129.25M

1251.40%26.27M

453.55%89.45M

-262.15%-51.03M

-16.44%101.69M

90.64%-2.28M

-224.14%-25.30M

105.94%31.47M

289.78%121.70M

-129.78%-24.39M

568.92%20.38M

-97.23%-530.08M

12.52%-64.13M

115.25%81.89M

-87.93%3.05M

-264.45%-268.77M

-491.59%-73.30M

143.38%38.05M

128.52%25.23M

---73.75M

--18.72M

5311.00%15.63M

---88.49M

--0.00

---300.00K

Net cash flow from other investing activities

----

--5.67M

----

Cash from non-current investing activities

Net cash flow from investing activities

120.20%25.27M

-14.15%108.41M

165.83%65.66M

-294.77%-170.41M

-133.97%-125.09M

28.73%126.28M

341.43%24.70M

310.93%87.49M

-310.07%-53.46M

-13.52%98.10M

71.72%-10.23M

-3186.85%-41.48M

104.74%25.45M

246.38%113.44M

-147.53%-36.17M

90.39%-1.26M

-92.16%-537.34M

4.83%-77.50M

116.06%76.11M

-157.45%-13.14M

-264.13%-279.63M

-591.74%-81.43M

147.84%35.23M

124.05%22.87M

-3162.19%-76.79M

247.58%16.56M

1594.64%14.21M

---95.08M

---2.35M

---11.22M

---951.00K

Financing cash flow

Cash flow from continuous financing activities

-79.59%96.61M

-45.24%1.89M

32.73%1.68M

733.83%1.11M

16240.32%473.38M

-89.78%3.44M

-96.57%1.26M

-99.88%133.00K

-97.06%2.90M

5.31%33.71M

2254.48%36.78M

381.39%107.54M

76.77%98.42M

48.60%32.01M

-99.51%1.56M

-86.08%22.34M

-78.02%55.68M

-83.43%21.54M

341268.09%320.89M

20695.38%160.44M

31.22%253.27M

18497.00%129.99M

-96.51%94.00K

-3795.00%-779.00K

409.16%193.01M

-99.42%699.00K

-72.77%2.69M

---20.00K

--37.91M

--120.07M

--9.89M

Net cash flow from debt Issuance/repayment

--93.89M

--0.00

100.00%0.00

49.75%-201.00K

82.66%-107.00K

70.65%-177.00K

-7.12%-632.00K

30.92%-400.00K

-9.20%-617.00K

-9.04%-603.00K

-8.86%-590.00K

-9.25%-579.00K

-9.28%-565.00K

-4.54%-553.00K

-144.03%-542.00K

-28.95%-530.00K

-19.68%-517.00K

-140.38%-529.00K

-40.90%1.23M

-111.32%-411.00K

---432.00K

--1.31M

--2.08M

--3.63M

----

--0.00

----

--0.00

Net cash flow from common stock issuance/repurchase

-99.68%1.51M

100.00%0.00

3.19%1.26M

---646.00K

33709.73%472.66M

-100.00%-1.00K

-96.63%1.22M

-100.00%0.00

-98.54%1.40M

5.36%33.60M

2079.63%36.27M

381.36%107.64M

72.68%95.69M

57.54%31.89M

-99.48%1.66M

-85.87%22.36M

-78.69%55.41M

-84.06%20.24M

--318.92M

--158.28M

35.06%260.00M

--127.02M

--0.00

--192.51M

----

--0.00

----

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--0.00

--37.90M

--120.06M

--10.00M

Proceeds from stock option exercised by employees

181.64%2.02M

-45.25%1.89M

72.38%412.00K

631.25%1.75M

-57.10%719.00K

362.42%3.44M

-81.50%239.00K

-65.81%240.00K

-50.59%1.68M

-2.49%745.00K

157.37%1.29M

8.67%702.00K

313.66%3.39M

-61.20%764.00K

-81.42%502.00K

-79.79%646.00K

-53.36%820.00K

-5.61%1.97M

385.10%2.70M

788.06%3.20M

1056.58%1.76M

4157.14%2.09M

587.65%557.00K

650.00%360.00K

2071.43%152.00K

390.00%49.00K

--81.00K

--48.00K

--7.00K

--10.00K

--0.00

Net cash flow from other financing activities

---813.00K

----

--0.00

----

100.00%0.00

-1436.00%-384.00K

-79.61%-185.00K

-933.33%-62.00K

57.81%-54.00K

88.04%-25.00K

80.34%-103.00K

99.92%-6.00K

62.57%-128.00K

-301.92%-209.00K

25.88%-524.00K

-730.38%-7.96M

76.13%-342.00K

94.90%-52.00K

-939.71%-707.00K

---958.00K

-143200.00%-1.43M

-786.96%-1.02M

---68.00K

--0.00

---1.00K

---115.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-79.59%96.61M

-45.24%1.89M

32.73%1.68M

733.83%1.11M

16240.32%473.38M

-89.78%3.44M

-96.57%1.26M

-99.88%133.00K

-97.06%2.90M

5.31%33.71M

2254.48%36.78M

381.39%107.54M

76.77%98.42M

48.60%32.01M

-99.51%1.56M

-86.08%22.34M

-78.02%55.68M

-83.43%21.54M

341268.09%320.89M

20695.38%160.44M

31.22%253.27M

18497.00%129.99M

-96.51%94.00K

-3795.00%-779.00K

409.16%193.01M

-99.42%699.00K

-72.77%2.69M

---20.00K

--37.91M

--120.07M

--9.89M

Net cash flow

Beginning cash balance

3.97%301.62M

15.99%274.62M

-3.40%288.76M

81.62%534.52M

-34.75%290.11M

33.21%236.75M

24.05%298.92M

13.38%294.30M

81.09%444.61M

5.00%177.73M

-13.44%240.97M

-16.15%259.57M

-57.13%245.52M

-73.00%169.26M

22.71%278.37M

176.20%309.57M

223.56%572.74M

310.40%626.86M

63.64%226.85M

-19.59%112.08M

250.15%177.01M

198.94%152.74M

170.87%138.63M

-11.58%139.38M

-65.83%50.55M

21.49%51.09M

20.33%51.18M

--157.63M

--147.94M

--42.06M

--42.53M

Current period cash flow changes

-102.72%-6.64M

-49.39%27.00M

77.24%-14.15M

-5422.76%-245.75M

262.60%244.41M

-80.01%53.36M

1.70%-62.16M

124.81%4.62M

-1169.70%-150.31M

249.97%266.88M

42.04%-63.24M

40.36%-18.61M

105.34%14.05M

240.90%76.26M

-127.28%-109.11M

-127.18%-31.20M

-305.32%-263.17M

-323.02%-54.12M

2735.13%400.01M

15444.12%114.77M

-173.10%-64.93M

4577.49%24.27M

16505.81%14.11M

99.30%-748.00K

816.05%88.83M

-100.51%-542.00K

81.97%-86.00K

---106.45M

--9.70M

--105.88M

---477.00K

Ending cash balance

-44.81%294.98M

3.97%301.62M

15.99%274.62M

-3.40%288.76M

81.62%534.52M

-34.75%290.11M

33.21%236.75M

24.05%298.92M

13.38%294.30M

81.09%444.61M

5.00%177.73M

-13.44%240.97M

-16.15%259.57M

-57.13%245.52M

-73.00%169.26M

22.71%278.37M

176.20%309.57M

223.56%572.74M

310.40%626.86M

63.64%226.85M

-19.59%112.08M

250.15%177.01M

198.94%152.74M

170.87%138.63M

-11.58%139.38M

-65.83%50.55M

21.49%51.09M

--51.18M

--157.63M

--147.94M

--42.06M

Free cash flow

-22.25%-130.75M

-9.69%-87.02M

3.58%-86.49M

6.34%-79.59M

-4.66%-106.95M

-160.34%-79.33M

8.22%-89.70M

15.74%-84.97M

11.78%-102.19M

269.76%131.48M

-13.27%-97.73M

-36.43%-100.85M

-154.84%-115.83M

-571.22%-77.45M

-3011.54%-86.28M

-51.75%-73.92M

521.99%211.23M

64.41%-11.54M

88.46%-2.77M

-93.27%-48.71M

-64.45%-50.06M

-62.44%-32.42M

-30.53%-24.03M

-40.50%-25.20M

-7.90%-30.44M

-40.68%-19.96M

-82.96%-18.41M

---17.94M

---28.21M

---14.19M

---10.06M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Beam Therapeutics Inc Generate?



Beam Therapeutics Inc generated -345.10M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Beam Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Beam Therapeutics Inc's operating cash flow increased by 0.62% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Beam Therapeutics Inc Spend on Capital Expenditures?



Beam Therapeutics Inc spent 14.95M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Beam Therapeutics Inc's Financing Cash Flow Changed?



Beam Therapeutics Inc used 478.05M in financing activities in the latest quarter.

What is free cash flow and why does it matter for BEAM?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Beam Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -360.05M reflecting a -1.08% change from the previous year.